Incidence of remission in adults with type 2 diabetes: the diabetes & aging study - PubMed (original) (raw)
. 2014 Dec;37(12):3188-95.
doi: 10.2337/dc14-0874. Epub 2014 Sep 17.
Affiliations
- PMID: 25231895
- PMCID: PMC4237974
- DOI: 10.2337/dc14-0874
Incidence of remission in adults with type 2 diabetes: the diabetes & aging study
Andrew J Karter et al. Diabetes Care. 2014 Dec.
Abstract
Objective: To estimate the incidence of remission in adults with type 2 diabetes not treated with bariatric surgery and to identify variables associated with remission.
Research design and methods: We quantified the incidence of diabetes remission and examined its correlates among 122,781 adults with type 2 diabetes in an integrated healthcare delivery system. Remission required the absence of ongoing drug therapy and was defined as follows: 1) partial: at least 1 year of subdiabetic hyperglycemia (hemoglobin A1c [HbA₁c] level 5.7-6.4% [39-46 mmol/mol]); 2) complete: at least 1 year of normoglycemia (HbA₁c level <5.7% [<39 mmol/mol]); and 3) prolonged: complete remission for at least 5 years.
Results: The incidence density (remissions per 1,000 person-years; 95% CI) of partial, complete, or prolonged remission was 2.8 (2.6-2.9), 0.24 (0.20-0.28), and 0.04 (0.01-0.06), respectively. The 7-year cumulative incidence of partial, complete, or prolonged remission was 1.47% (1.40-1.54%), 0.14% (0.12-0.16%), and 0.007% (0.003-0.020%), respectively. The 7-year cumulative incidence of achieving any remission was 1.60% in the whole cohort (1.53-1.68%) and 4.6% in the subgroup with new-onset diabetes (<2 years since diagnosis) (4.3-4.9%). After adjusting for demographic and clinical characteristics, correlates of remission included age >65 years, African American race, <2 years since diagnosis, baseline HbA₁c level <5.7% (<39 mmol/mol), and no diabetes medication at baseline.
Conclusions: In community settings, remission of type 2 diabetes does occur without bariatric surgery, but it is very rare.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
References
- Saudek CD. Can diabetes be cured? Potential biological and mechanical approaches. JAMA 2009;301:1588–1590 - PubMed
- UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
- Turner RC, Cull CA, Frighi V, Holman RR, UK Prospective Diabetes Study (UKPDS) Group . Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999;281:2005–2012 - PubMed
- Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012;366:1577–1585 - PubMed
Publication types
MeSH terms
Grants and funding
- T32 HS000084/HS/AHRQ HHS/United States
- R01 HD046113/HD/NICHD NIH HHS/United States
- P30-DK-092949/DK/NIDDK NIH HHS/United States
- R01 DK065664/DK/NIDDK NIH HHS/United States
- R01 DK080726/DK/NIDDK NIH HHS/United States
- P30 DK092924/DK/NIDDK NIH HHS/United States
- T32-HS-00084/HS/AHRQ HHS/United States
- R01-DK-081796/DK/NIDDK NIH HHS/United States
- R01 DK081796/DK/NIDDK NIH HHS/United States
- P30 DK092949/DK/NIDDK NIH HHS/United States
- P30-DK-092924/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical